Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor.

Cell | Mar 19, 1999

http://www.ncbi.nlm.nih.gov/pubmed/10102273

Survival factors can suppress apoptosis in a transcription-independent manner by activating the serine/ threonine kinase Akt, which then phosphorylates and inactivates components of the apoptotic machinery, including BAD and Caspase 9. In this study, we demonstrate that Akt also regulates the activity of FKHRL1, a member of the Forkhead family of transcription factors. In the presence of survival factors, Akt phosphorylates FKHRL1, leading to FKHRL1's association with 14-3-3 proteins and FKHRL1's retention in the cytoplasm. Survival factor withdrawal leads to FKHRL1 dephosphorylation, nuclear translocation, and target gene activation. Within the nucleus, FKHRL1 triggers apoptosis most likely by inducing the expression of genes that are critical for cell death, such as the Fas ligand gene.

Pubmed ID: 10102273 RIS Download

Mesh terms: 14-3-3 Proteins | Apoptosis | Binding Sites | Cell Line, Transformed | Cell Survival | Cytoplasm | DNA-Binding Proteins | Fas Ligand Protein | Forkhead Transcription Factors | Humans | Membrane Glycoproteins | Phosphorylation | Protein-Serine-Threonine Kinases | Proteins | Proto-Oncogene Proteins | Proto-Oncogene Proteins c-akt | Recombinant Fusion Proteins | Transcription Factors | Tyrosine 3-Monooxygenase

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, Id: CA43855
  • Agency: NCI NIH HHS, Id: CA46595
  • Agency: NICHD NIH HHS, Id: HD 18655

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.